Therapeutics Company Plans Move to Bedford Woburn-Based Anika to Take Old Millipore Site
102182
By Tom Spoth, The Sun, Lowell, Mass.  Jan. 30--BEDFORD -- A Woburn therapeutics company plans to move its headquarters to a 130,000-square-foot building on Wiggins Avenue, bringing 65 employees to town.
705195
Anesiva's pain medication is moving up the clinical trial ladder.
708968
Massachusetts is about to lose another corporate headquarters -- but not many jobs. In a $1.5 billion deal made public yesterday, Wakefield's PolyMedica Corp. , a mail-order company that sells drugs and supplies to diabetes patients, agreed to sell itself to Medco Health Solutions Inc., the country's biggest manager of drug benefits.
639985
As part of its push to become a bigger player in cancer drugs, Genzyme Corp. of Cambridge said yesterday it will buy out business partner Bioenvision Inc. of New York for $345 million , consolidating its ownership of a cancer treatment to which the two companies had been sharing rights.
65762
The stunning announcement is likely to damage the companyÂs prospects for decades as research linked the drug to deaths and heart problems.
303789
Schering-Plough and Bayer have announced an agreement under which New Jersey-based Schering will attain US marketing rights to Bayer HealthCareâs primary care pharmaceutical products, including the antibiotics Avelox (moxifloxacin HCL) and Cipro
658871
Boston Scientific Corp. , the medical device maker, eliminated 55 jobs in Marlborough last month, according to the state Executive Office of Labor and Workforce Development. Company spokesman Paul Donovan said the Natick firm made the cuts after deciding to pull the plug on its Endovations program, an effort to develop a new single-use endoscope with an integrated ...
58200
Company aquires some assets of Tribe.net, and expects to let the site remain independent.
626533
GlaxoSmithKline Plc is preparing for a  "renaissance" of its oncology business, led by Tykerb, a novel  pill that is expected to win U.S. regulatory approval for  breast cancer next month.
738382
The drug maker is poised to speed past its rivals.
322638
Epoch Biosciences, a small Bothell company that makes tools to speed up genetic analysis, said yesterday it has agreed to be sold to San Diego-based Nanogen for about $60 million in stock.
524733
One of the UKâs biggest insurance firms today announced plans to transfer more than 1,100 jobs to India over the next few years, sparking fears of a âcrisisâ in Britain.
219400
The former will take over development of the latter's drug.
466497
Adnexus Therapeutics Inc., an ambitious young biotech company in Waltham, says it is going public.
462115
Sepracor Inc. , the Marlborough drug maker behind the Lunesta sleep aid, plans to nearly double the size of its headquarters, the latest in a wave of expansion by Massachusetts life sciences companies.
561889
By Sabine Vollmer, The News & Observer, Raleigh, N.C.  Sep. 9--Peyton Anderson has big plans for Affinergy, the three-year-old medical device company he runs in south Durham.
685744
The Medicines Company reacquires its own drug.